Sfoglia per Rivista UROLOGIC ONCOLOGY
Mostrati risultati da 1 a 2 di 2
The efficacy of BCG Tice and BCG Connaught in a cohort of 2099 T1G3 non-muscle invasive bladder cancer patients
2016 Witjes, Ja; Dalbagni, 2; Karnes, Rj; Shariat, S; Joniau, S; Palou, J; Serretta, V; Larré, S; di Stasi, S; Colombo, R; Babjuk, M; Malmström, Pu; Malats, N; Irani, J; Baniel, J; Cai, T; Cha, E; Ardelt, P; Varkarakis, J; Bartoletti, R; Spahn, M; Pisano, F; Gontero, Paolo; Sylvester, R
Phase II study of biweekly gemcitabine as first line therapy in CIS of the bladder: What does an aborted trial tell us?
2013 P., Gontero; C., Fiorito; Oderda, Marco; G., Pappagallo; M., Brausi
Citazione | Data di pubblicazione | Autori | File |
---|---|---|---|
The efficacy of BCG Tice and BCG Connaught in a cohort of 2099 T1G3 non-muscle invasive bladder cancer patients / Witjes, Ja; Dalbagni, 2; Karnes, Rj; Shariat, S; Joniau, S; Palou, J; Serretta, V; Larré, S; di Stasi, S; Colombo, R; Babjuk, M; Malmström, Pu; Malats, N; Irani, J; Baniel, J; Cai, T; Cha, E; Ardelt, P; Varkarakis, J; Bartoletti, R; Spahn, M; Pisano, F; Gontero, Paolo; Sylvester, R. - In: UROLOGIC ONCOLOGY. - ISSN 1078-1439. - (2016). | 1-gen-2016 | Pisano FGONTERO, PAOLO + | - |
Phase II study of biweekly gemcitabine as first line therapy in CIS of the bladder: What does an aborted trial tell us? / P., Gontero; C., Fiorito; Oderda, Marco; G., Pappagallo; M., Brausi. - In: UROLOGIC ONCOLOGY. - ISSN 1078-1439. - 80:3(2013), pp. 247-250. [10.1016/j.urolonc.2011.03.011] | 1-gen-2013 | ODERDA, MARCO + | - |
Mostrati risultati da 1 a 2 di 2
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile